Company Encyclopedia
View More
name
Phreesia
PHR.US
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers an appointment scheduling system for online appointments, reminders, and referral tracking and management; registration solutions to automate patient self-registration; revenue cycle solutions that provide insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network solutions to deliver clinically relevant content to patients. It deploys its platform in a range of modalities, including Phreesia Mobile, a patients’ mobile device; PhreesiaPads, a self-service intake tablets; Phreesia Dashboard, a web-based dashboard for healthcare services clients; and Arrivals Kiosks, which are on-site kiosks.
70.40 B
PHR.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
Health Care TechnologyIndustry
Industry Ranking4/44
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-8.76%D
    • Profit Margin-5.35%D
    • Gross Margin67.90%A
  • Growth ScoreB
    • Revenue YoY15.31%B
    • Net Profit YoY76.02%A
    • Total Assets YoY12.81%B
    • Net Assets YoY18.56%A
  • Cash ScoreC
    • Cash Flow Margin-1869.50%E
    • OCF YoY15.31%B
  • Operating ScoreA
    • Turnover1.17A
  • Debt ScoreB
    • Gearing Ratio27.08%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Megan Turco of Phreesia named to MM+M 2025 40 Under 40 list as Director of Client Experience for Phreesia Network Solutions.

    An announcement was made by Phreesia concerning Megan Turco, who serves as the Director of Client Experience for Phreesia Network Solutions. She has been recognized for her achievements by being selected for MM+M’s prestigious 40 Under 40 list for 2025. Megan Turco's exceptional work in her role has earned her this accolade in the field of healthcare and marketing.

    Unusual Whales·
    US
    PHR
    +0.83%
    Unusual Whales·
    US
    PHR
    +0.83%

    Phreesia (PHR) Valuation Check as Analyst Upgrades Lift Earnings Expectations and Renew Market Interest

    Analysts have upgraded Phreesia's earnings forecasts, sparking renewed market interest despite recent share price declines. The stock is considered undervalued, with a fair value of $33.73 against its current price of $20.15. Growth expectations are supported by new modules and AI integration, enhancing revenue and margins. However, regulatory changes and slower module adoption pose risks. Investors are encouraged to explore healthcare stocks for potential opportunities.

    Simplywall·
    US
    PHR
    +0.83%
    Simplywall·
    US
    PHR
    +0.83%

    Phreesia (PHR): Exploring Valuation Following Fresh 'Outperform' Rating and Analyst Optimism

    Phreesia (PHR) received an 'Outperform' rating from BMO Capital, adding to existing analyst optimism. Despite a 25% share price drop in the last 90 days, the company has a 20.7% total shareholder return over the past year. Analysts debate if Phreesia is undervalued, with a fair value of $33.73. The company's growth is driven by new value-added modules, though competitive pressures and regulatory changes pose risks.

    Simplywall·
    US
    PHR
    +0.83%
    Simplywall·
    US
    PHR
    +0.83%

    Phreesia shares are trading higher after BMO Capital initiated coverage on the stock with an Outperform rating and a $32 price target.

    benzinga_article·
    US
    PHR
    +0.83%
    benzinga_article·
    US
    PHR
    +0.83%

    Phreesia Secures $110 Million Bridge Loan Led by Goldman Sachs for AccessOne Acquisition

    Phreesia Inc. has secured a $110 million bridge loan led by Goldman Sachs to finance its acquisition of AccessOne. The loan, which has a term of 364 days, will also cover related fees and expenses. Phreesia plans to refinance this short-term loan with a long-term credit facility in the future. Additionally, the company amended its existing agreements with Capital One to ensure compliance with the acquisition and the new loan terms.

    Reuters·
    US
    PHR
    +0.83%
    Reuters·
    US
    PHR
    +0.83%
    © 2025 Longbridge｜Disclaimer